Methods for treating conditions associated with masp-2 dependent complement activation
US-2024228665-A1 · Jul 11, 2024 · US
This page is not indexed by search engines while we improve data quality.
Tedford Clark E patents
Tedford Clark E is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tedford Clark E |
| Total patents | 32 |
| First publication | Mar 5, 2015 |
| Latest publication | Jul 11, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions for inhibiting masp-2 dependent complement activation
US-2024092938-A1 · Mar 21, 2024 · US
Methods for treating conditions associated with masp-2 dependent complement activation
US-2024076408-A1 · Mar 7, 2024 · US
Methods for treating conditions associated with MASP-2 dependent complement activation
US-11884742-B2 · Jan 30, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2023391889-A1 · Dec 7, 2023 · US
Compositions for inhibiting MASP-2 dependent complement activation
US-11613589-B2 · Mar 28, 2023 · US
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US-2022175726-A1 · Jun 9, 2022 · US
Compositions for inhibiting masp-2 dependent complement activation
US-2021054099-A1 · Feb 25, 2021 · US
Methods for treating conditions associated with masp-2 dependent complement activation
US-2021040229-A1 · Feb 11, 2021 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2020190215-A1 · Jun 18, 2020 · US
Recent patents
Latest publications not already listed above.
Compositions for inhibiting MASP-2 dependent complement activation
US-10683367-B2 · Jun 16, 2020 · US
Methods for treating conditions associated with masp-2 dependent complement activation
US-2020157245-A1 · May 21, 2020 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2020040104-A1 · Feb 6, 2020 · US
Compositions for Inhibiting MASP-2 Dependent Complement Activation
US-2019119402-A1 · Apr 25, 2019 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2018291111-A1 · Oct 11, 2018 · US
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
US-2018291112-A1 · Oct 11, 2018 · US
Compositions for inhibiting MASP-2 dependent complement activation
US-10047165-B2 · Aug 14, 2018 · US
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US-2018085349-A1 · Mar 29, 2018 · US
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US-9855246-B2 · Jan 2, 2018 · US
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
US-2017233494-A1 · Aug 17, 2017 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2017233493-A1 · Aug 17, 2017 · US
Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
US-2017196838-A1 · Jul 13, 2017 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2017166660-A1 · Jun 15, 2017 · US
Compositions for inhibiting masp-2 dependent complement activation
US-2017088632-A1 · Mar 30, 2017 · US
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US-9486406-B2 · Nov 8, 2016 · US
Compositions for inhibiting MASP-2 dependent complement activation
US-9475885-B2 · Oct 25, 2016 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2016272727-A1 · Sep 22, 2016 · US
Compositions for inhibiting masp-2 dependent complement activation
US-2016002349-A1 · Jan 7, 2016 · US
Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
US-2015342928-A1 · Dec 3, 2015 · US
Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US-9066856-B2 · Jun 30, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Omeros Corp | 32 |
| Univ Leicester | 15 |
| Dudler Thomas | 1 |
| Gombotz Wayne R | 1 |
| Parent James Brian | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/40 | 25 |
| C07K2317/76 | 25 |
| C07K2317/92 | 25 |
| A61K2039/505 | 25 |
| C07K2317/54 | 25 |